Financials ChemoMetec A/S

Equities

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:50 2024-06-04 am EDT			5-day change	1st Jan Change
332.6 ^DKK	-2.58%		-5.40%	-14.28%

May. 27	Denmark's ChemoMetec Appoints New CFO	MT
May. 24	ChemoMetec A/S Announces CFO Changes	CI

Valuation

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Capitalization ¹	14,679	13,174	8,110	5,788	-	-
Enterprise Value (EV) ¹	14,679	13,174	7,800	5,450	5,392	5,338
P/E ratio	166 x	82.6 x	45.4 x	45.4 x	37.9 x	32 x
Yield	-	0.53%	-	1.3%	1.6%	1.7%
Capitalization / Revenue	-	30.8 x	18.3 x	14.3 x	12.6 x	10.9 x
EV / Revenue	-	30.8 x	17.6 x	13.5 x	11.7 x	10.1 x
EV / EBITDA	-	59.1 x	31.1 x	29.1 x	24.9 x	20.9 x
EV / FCF	-	-	68.8 x	56.5 x	39.9 x	36.1 x
FCF Yield	-	-	1.45%	1.77%	2.5%	2.77%
Price to Book	-	-	15.2 x	9.79 x	8.66 x	7.65 x
Nbr of stocks (in thousands)	17,402	17,402	17,402	17,402	-	-
Reference price ²	843.5	757.0	466.0	332.6	332.6	332.6
Announcement Date	9/17/21	9/15/22	9/13/23	-	-	-

¹DKK in Million²DKK

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Net sales ¹	-	427.2	442.3	404.3	460.7	529.9
EBITDA ¹	-	222.9	251	187.2	217	255.8
EBIT ¹	-	202.9	230.6	168	195.5	231.7
Operating Margin	-	47.48%	52.13%	41.55%	42.44%	43.72%
Earnings before Tax (EBT) ¹	-	-	230.4	168.9	195.8	231.6
Net income ¹	88.35	159.5	178.7	127.3	152.8	181
Net margin	-	37.34%	40.4%	31.5%	33.16%	34.15%
EPS ²	5.080	9.160	10.27	7.326	8.780	10.40
Free Cash Flow ¹	-	-	113.3	96.5	135	147.7
FCF margin	-	-	25.62%	23.87%	29.3%	27.87%
FCF Conversion (EBITDA)	-	-	45.15%	51.55%	62.22%	57.72%
FCF Conversion (Net income)	-	-	63.43%	75.78%	88.37%	81.59%
Dividend per Share ²	-	4.000	-	4.333	5.333	5.667
Announcement Date	9/17/21	9/15/22	9/13/23	-	-	-

¹DKK in Million²DKK

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June	2024 Q2	2024 S1	2024 Q3	2024 Q4	2024 S2	2025 S1	2025 S2
Net sales ¹	108.1	199.3	98.9	105.5	203	216	224
EBITDA ¹	51.6	93.1	43.1	49.2	91	101	96
EBIT ¹	-	84.65	43.5	49.2	82	92	86
Operating Margin	-	42.47%	43.98%	46.64%	40.39%	42.59%	38.39%
Earnings before Tax (EBT)	-	89.02	-	-	83	93	88
Net income ¹	-	70.56	43.5	49.2	65	72	68
Net margin	-	35.4%	43.98%	46.64%	32.02%	33.33%	30.36%
EPS ²	-	4.050	2.500	2.830	3.720	4.160	3.920
Dividend per Share	-	-	-	-	-	-	-
Announcement Date	2/5/24	2/5/24	5/8/24	-	-	-	-

¹DKK in Million²DKK

Estimates

Balance Sheet Analysis

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	-	-	-	-
Net Cash position ¹	-	-	309	338	396	450
Leverage (Debt/EBITDA)	-	-	-	-	-	-
Free Cash Flow ¹	-	-	113	96.5	135	148
ROE (net income / shareholders' equity)	-	51.4%	39.5%	22.7%	24.5%	26.2%
ROA (Net income/ Total Assets)	-	-	-	19.4%	19.6%	21.1%
Assets ¹	-	-	-	657.7	778.9	859.4
Book Value Per Share ²	-	-	30.60	34.00	38.40	43.50
Cash Flow per Share ²	-	10.20	8.860	8.000	10.40	12.20
Capex ¹	-	-	40.8	52.5	42.1	51.7
Capex / Sales	-	-	9.23%	12.98%	9.14%	9.76%
Announcement Date	9/17/21	9/15/22	9/13/23	-	-	-

¹DKK in Million²DKK

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for ChemoMetec A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

332.6 DKK

Average target price

437.5 DKK

Spread / Average Target

+31.54%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
CHEMOMETEC A/S	-14.28%	844M
SHOCKWAVE MEDICAL, INC.	+75.69%	12.57B
MASIMO CORPORATION	+6.32%	6.9B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+14.03%	5.79B
GETINGE AB	-16.76%	4.86B
APT MEDICAL INC.	+20.13%	4.27B
ASAHI INTECC CO., LTD.	-18.62%	3.96B
INARI MEDICAL, INC.	-22.44%	2.87B
NOVOCURE LIMITED	+54.92%	2.46B
SKAN GROUP AG	+1.49%	2.04B

Medical Equipment